Automation and standardization of the glucose measurement process have the potential to greatly improve glycemic control, clinical outcome, and safety while reducing cost. The resources required to monitor glycemia in hospitalized patients have thus far limited the implementation of intensive glucose management to patients in critical care units. Numerous available and up-and-coming technologies are targeted for the hospital patient population. Advantages and limitations of these devices are discussed herewith in.
KrinsleyJS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc.2003;78 (12): 1471–8.
2.
KrinsleyJSGroverA. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med.2007;35 (10): 2262–7.
3.
ClementSBraithwaiteSSMageeMFAhmannASmithEPSchaferRGHirschIB; American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care.27 (2): 553–91.
4.
CryerPE. Hypoglycaemia: the limiting factor in the glycaemic management of the critically ill?. Diabetologia.2006;49 (8): 1722–5.
5.
BraithwaiteSSBuieMMThompsonCLBaldwinDFOertelMDRobertsonBAMehrotraHP. Hospital hypoglycemia: not only treatment but also prevention. Endocr Pract.2004;10Suppl 2: 89–99.
6.
FischerKFLeesJANewmanJH. Hypoglycemia in hospitalized patients. Causes and outcomes. N Engl J Med.1986;315 (20): 1245–50.
7.
WexlerDJMeigsJBCaglieroENathanDMGrantRW. Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals. Diabetes Care.2007;30 (2): 367–9.
8.
Van den BergheGWoutersPWeekersFVerwaestCBruyninckxFSchetzMVlasselaersDFerdinandePLauwersPBouillonR. Intensive insulin therapy in the critically ill patients. N Engl J Med.2001;345 (19): 1359–67.
9.
AragonD. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care.2006;15 (4): 370–7.
10.
JosephJI. Management of the diabetic surgical patient. In: Textbook of type 2 diabetes. Martin Dunitz; 2007.
11.
InzucchiSE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med.2006;355 (18): 1903–11.
12.
WilsonMWeinrebJHooGW. Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care.2007;30 (4): 1005–11.
13.
LipshutzAKGropperMA. Perioperative glycemic control: an evidence-based review. Anesthesiology.2009;110 (2): 408–21.
14.
BodeBWBraithwaiteSSSteedRDDavidsonPC. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract.2004;10Suppl 2: 71–80.
15.
ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract.2006;12 (4): 458–68.
16.
GarberAJMoghissiESBransomeEDJrClarkNGClementSCobinRHFurnaryAPHirschIBLevyPRobertsRVan den BergheGZamudioV; American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract.10 (1): 77–82.
17.
MoghissiESKorytkowskiMTDiNardoMEinhornDHellmanRHirschIBInzucchiSEIsmail-BeigiFKirkmanMSUmpierrezGE; American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract.15 (4): 353–69.
18.
GoldbergPASiegelMDRussellRRSherwinRSHalickmanJICooperDADziuraJDInzucchiSE. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther.2004;6 (3): 339–47.
19.
VriesendorpTMDeVriesJHHollemanFDzoljicMHoekstraJB. The use of two continuous glucose sensors during and after surgery. Diabetes Technol Ther.2005;7 (2): 315–22.
20.
GaneshAHipszerBLoombaNTorjmanMCJosephJ. Evaluation of the VIA blood chemistry monitor for glucose in healthy and diabetic volunteers. J Diabetes Sci Technol.2008;2 (2): 182,182–93.
21.
HipszerBFurlongKJLessinJBGrunwaldZJosephJI. Continuous glucose monitoring in the perioperative period. Anesthesiology.2006;105: A583.
22.
HipszerBChervonevaIGratchDMHeitzJWMaguireDPYeoCJGrunwaldZJosephJI. The performance of subcutaneous glucose sensors in surgical patients. J Diabetes Sci Technol.2008;2 (2): A71.
23.
De BlockCManuel-Y-KeenoyBVan GaalLRogiersP. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care.2006;29 (8): 1750–6.
24.
MurakamiAGutierrezMALageSHRebeloMFGuiraldelliRHRamiresJA. A continuous glucose monitoring system in critical cardiac patients in the intensive care unit. Comput Cardiol.2006: 233–6.
25.
CorstjensAMLigtenbergJJvan der HorstICSpanjersbergRLindJSTullekenJEMeertensJHZijlstraJG. Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients. Crit Care.2006;10 (5): R135.
26.
BochicchioGVBochicchioKMLettichKLambertPHerreraALumpkinsKScaleaTMagarianP. Cutting edge technology in tight glycemic control (TGC). Crit Care Med.2007;35Suppl: A142.
27.
MonsodTPFlanaganDERifeFSaenzRCaprioSSherwinRSTamborlaneWV. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia?. Diabetes Care.2002;25 (5): 889–93.
28.
AussedatBDupire-AngelMGiffordRKleinJCWilsonGSReachG. Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. Am J Physiol Endocrinol Metab.2000;278 (4): E716–28.
29.
CheeFFernandoTvan HeerdenPV. Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time. IEEE Trans Inf Technol Biomed.2003;7 (1): 43–53.
30.
WidnessJAKulhavyJCJohnsonKJCressGAKromerIJAcarreguiMJFeldRD. Clinical performance of an in-line point-of-care monitor in neonates. Pediatrics.2000;106 (3): 497–504.
31.
GargSK. The future of continuous glucose monitoring. Diabetes Technol Ther.2009;11Suppl 1: S1–3.
32.
McGarraughG. The chemistry of commercial continuous glucose monitors. Diabetes Technol Ther.2009;11Suppl 1: S17–24.
33.
JosephJIGoldsteinBJ. New devices and drugs on the horizon. In: GoldsteinBJMuller-WielandD, editors. Textbook of type 2 diabetes. Informa Healthcare; 2003. p. 447–56.
34.
RossettiPPorcellatiFFanelliCGBolliGB. Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyper-glycemia in humans. Diabetes Technol Ther.2006;8 (3): 326–37.
35.
AllenHFRakeARoyMBrennerDMcKiernanCA. Prospective detection of hyperglycemia in critically ill children using continuous glucose monitoring. Pediatr Crit Care Med.2008;9 (2): 153–8.
36.
ReachG. Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. Diabetes Technol Ther.2008;10 (2): 69–80.
37.
RodbardD. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther.2009;11Suppl 1: S55–67.
38.
KovatchevBPGonder-FrederickLACoxDJClarkeWL. Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense freestyle navigator data. Diabetes Care.2004;27 (8): 1922–8.
39.
UmpierrezGESmileyDZismanAPrietoLMPalacioACeronMPuigAMejiaR. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care.2007;30 (9): 2181–6.
40.
TorjmanMCDalalNGoldbergME. Glucose monitoring in acute care: technologies on the horizon. J Diabetes Sci Technol.2008;2 (2): 178–81.
41.
Van den BergheGWoutersPJBouillonRWeekersFVerwaestCSchetzMVlasselaersDFerdinandePLauwersP. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med.2003;31 (2): 359–66.
42.
Van den BergheGWilmerAHermansGMeerssemanWWoutersPJMilantsIVan WijngaerdenEBobbaersHBouillonR. Intensive insulin therapy in the medical ICU. N Engl J Med.2006;354 (5): 449–61.
43.
PlankJBlahaJCordingleyJWilinskaMEChassinLJMorganCSquireSHaluzikMKremenJSvacinaSTollerWPlasnikAEllmererMHovorkaRPieberTR. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients: response to Ligtenberg et al. Diabetes Care.2006;29 (8): 1987–8.
44.
CheeFFernandoTvan HeerdenPV. Closed-loop control of blood glucose levels in critically ill patients. Anaesth Intensive Care.2002;30 (3): 295–307.
45.
ChaseJGShawGMLinJDoranCVHannCLotzTWakeGC, Broughton B.Targeted glycemic reduction in critical care using closed-loop control. Diabetes Technol Ther.2005;7 (2): 274–82.
46.
GallettiPMKuntschenFRHahnC. Experimental and clinical studies with servo-controlled glucose and insulin administration during cardiopulmonary bypass. Mt Sinai J Med.1985;52 (7): 500–7.
47.
SchwartzSSHorwitzDLZehfusBLangerBMoossaARRibeiroGKaplanERubensteinAH. Use of a glucose controlled insulin infusion system (artificial beta cell) to control diabetes during surgery. Diabetologia.1979;16 (3): 157–64.
48.
SteedRDDavidsonPCBodeBWSivitzWI. Computer-controlled intravenous insulin infusion using intermittent bedside glucose monitoring: one year's experience. Diabetes.1986;35Suppl. 1: 32A.
49.
DavidsonPCSteedRDBodeBW. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care.2005;28 (10): 2418–23.
SchallerRFeichtnerFKohlerHBodenlenzMPlankJWutteAMaderJKEllmererMHellmichRWedigHHainischRPieberTRSchauppL. A novel automated discontinuous venous blood monitoring system for ex vivo glucose determination in humans. Biosens Bioelectron.2009;24 (7): 2239–45.
52.
KadishAH. A servomechanism for blood sugar control. Biomed Sci Instrum.1963;1: 171–6.
53.
AlbisserAMLeibelBSEwartTGDavidovacZBotzCKZinggW. An artificial endocrine pancreas. Diabetes.1974;23 (5): 389–96.
54.
OkabayashiTHnazakiKNishimoriISugimotoTMaedaHYatabeTDabanakaKKobayashiMYamashitaK. Continuous post-operative blood glucose monitoring and control using a closed-loop system in patients undergoing hepatic resection. Dig Dis Sci.2008;53 (5): 1405–10.
55.
YamashitaKOkabayashiTYokoyamaTYatabeTMaedaHManabeMHanazakiK. The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg.2008;106 (1): 160–3, table of contents.
56.
YamashitaKOkabayashiTYokoyamaTYatabeTMaedaHManabeMHanazakiK. Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesthesiol Scand.2009;53 (1): 66–71.
57.
OzyolMBHerfarthCKernerWPfeifferEF. Postoperative blood-sugar regulation in pancreatectomized patients using the artificial “beta cell”. Chirurg.1979;50 (4): 227–32.
58.
GinHCatargiBRigalleauVRullierERogerPTabarinA. Experience with the Biostator for diagnosis and assisted surgery of 21 insulinomas. Eur J Endocrinol.1998;139 (4): 371–7.
59.
LucisanoJYEdelmanSVQuintoBDWongDK. Development of a biosensor-based, patient-attached blood glucose monitoring system. Proc Am Chem Soc.1997;76: 256.
60.
VIA blood chemistry monitor for glucose VIA V-GLU 1 operator's manual. San Diego, CA: VIA Medical Corporation; 1998.
PlankJSchallerREllmererMKollerDEberhardtRKohlerGShoemakerMObermaierKTollerWPieberTSchauppL. Continuous glucose monitoring using the SCGM1 system in postcardiothoracic surgery patients. Crit Care.2006;10 (Suppl 1): P254. Available from: http://ccforum.com/supplements/10/S1
63.
HeiseHMKondepatiVRDammULichtMFeichtnerFMaderJMEllmererM. Microdialysis based monitoring of subcutaneous interstitial and venous blood glucose in type 1 diabetic subjects by mid-infrared spectrometry for intensive insulin therapy. Optical Diagnostics Sensing VIII. January 2008.
64.
HeiseHMDammUBodenlenzMKondepatiVRKohlerGEllmererM. Bedside monitoring of subcutaneous interstitial glucose in healthy individuals using microdialysis and infrared spectrometry. J Biomed Opt.2007;12 (2): 024004.
65.
ChuangHTrieuMHurleyJTaylorEJEnglandMRNasrawayStanleyAJr.Pilot studies of transdermal continuous glucose measurement in outpatient diabetic patients and in patients during and after cardiac surgery. J Diabetes Sci Technol.2008 2008; 2 (4): 595–602.
HipszerBJosephJI. Lag associated with interstitial glucose sensors used in a diabetic surgical patient. Anesthesiology. 2006 2006; 105: A584.
71.
SimonBTreatVMarcoCRosenbergDJosephJHipszerBLiYChervonevaIPadron-MassaraLJabbourS. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS. Int J Clin Pract.2008;62 (12): 1858–63.
72.
LodwigVHeinemannL; Glucose Monitoring Study Group. Continuous glucose monitoring with glucose sensors: calibration and assessment criteria. Diabetes Technol Ther.5 (4): 572–86.
73.
McGarraughGBergenstalR. Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle navigator continuous glucose monitoring system. Diabetes Technol Ther.2009;11 (3): 145–50.
74.
WardWKCaseyHMQuinnMJFederiukIFWoodMD. A fully implantable subcutaneous glucose sensor array: enhanced accuracy from multiple sensing units and a median-based algorithm. Diabetes Technol Ther.2003;5 (6): 943–52.
75.
PiperHGAlexanderJLShuklaAPigulaFCostelloJMLaussenPCJaksicTAgusMS. Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery. Pediatrics.2006;118 (3): 1176–84.
76.
LogtenbergSJKleefstraNSnellenFTGroenierKHSlingerlandRJNierichAPBiloHJ. Pre- and postoperative accuracy and safety of a real-time continuous glucose monitoring system in cardiac surgical patients: a randomized pilot study. Diabetes Technol Ther.2009;11 (1): 31–7.
77.
BaileyPLMcJamesSWCluffMLWellsDTOrrJAWestenskowDRKernSE. Evaluation in volunteers of the VIA V-ABG automated bedside blood gas, chemistry, and hematocrit monitor. J Clin Monit Comput.1998;14 (5): 339–46.
78.
KunjanKLloydFPJr.Automated blood sampling and glucose sensing in critical care settings. J Diabetes Sci Technol.2008;2 (2): 194–200.
79.
KovatchevBAndersonSHeinemannLClarkeW. Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care.2008;31 (6): 1160–4.
80.
SacksDBBernhardtPDunkaLJGoldsteinDEHortinGLMuellerP. Point-of-care blood glucose testing in acute and chronic care facilities; approved guideline. NCCLS.2002;22 (17).
81.
DesachyAVuagnatACGhazaliADBaudinOTLonguetOHCalvatSNGissotV. Accuracy of bedside glucometry in critically ill patients: influence of clinical characteristics and perfusion index. Mayo Clin Proc.2008;83 (4): 400–5.
82.
KanjiSBuffieJHuttonBBuntingPSSinghAMcDonaldKFergussonDMcIntyreLAHebertPC. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med.2005;33 (12): 2778–85.
83.
FahyBGCoursinDB. Critical glucose control: the devil is in the details. Mayo Clin Proc.2008;83 (4): 394–7.
84.
FinkielmanJDOyenLJAfessaB. Agreement between bedside blood and plasma glucose measurement in the ICU setting. Chest.2005;127 (5): 1749–51.
85.
HooGW Soo. Tight blood glucose control in the ICU: how best to measure glucose control?. Chest.2008;133 (1): 316–7; author reply 317.
86.
NicholsJH. What is accuracy and how close must the agreement be?. Diabetes Technol Ther.2005;7 (3): 558–62.
87.
SylvainHFPokornyMEEnglishSMBensonNHWhitleyTWFerenczyCJHarrisonJG. Accuracy of fingerstick glucose values in shock patients. Am J Crit Care.1995;4 (1): 44–8.
88.
DunganKChapmanJBraithwaiteSSBuseJ. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care.2007;30 (2): 403–9.
89.
TorjmanMCJahnLJosephJICrothallK. Accuracy of the hemocue portable glucose analyzer in a large nonhomogeneous population. Diabetes Technol Ther.2001;3 (4): 591–600.
90.
Slater-MacLeanLCembrowskiGChinDShalapayCBinetteTHegadorenKNewburn-CookC. Accuracy of glycemic measurements in the critically ill. Diabetes Technol Ther.2008;10 (3): 169–77.
91.
KaronBSGriesmannLScottRBryantSCDuboisJAShireyTLPrestiSSantrachPJ. Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meters. Diabetes Technol Ther.2008;10 (2): 111–20.
92.
KaronBSGandhiGYNuttallGABryantSCSchaffHVMcMahonMMSantrachPJ. Accuracy of roche accu-chek inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgery. Am J Clin Pathol.2007;127 (6): 919–26.
93.
BoydJCBrunsDE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem.2001;47 (2): 209–14.
NayakPPMorrisKLangHLakerSStickleyJDaviesPBarrettTGaoFGoughSNarendranP. Lack of agreement between arterial and central venous blood glucose measurement in critically ill children. Intensive Care Med.2009;35 (4): 762–3.
96.
FloodJJosephJKimLMcNultySChervonevaI. Glucose levels in blood simultaneously sampled from the radial artery, vena cava, and fingertip. Anesthesiology.2007;107: A1123.
97.
NICE-SUGAR Study Investigators, FinferSChittockDRSuSYBlairDFosterDDhingraVBellomoRCookDDodekPHendersonWRHébertPCHeritierSHeylandDKMcArthurCMcDonaldEMitchellIMyburghJANortonRPotterJRobinsonBGRoncoJJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med.2009;360 (13): 1283–97.
GoldbergPASiegelMDSherwinRSHalickmanJILeeMBaileyVALeeSLDziuraJDInzucchiSE. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care.2004;27 (2): 461–7.
100.
RyanMSavereseVHipszerBDizdarevicIJosephMShivelyNJosephJI. Continuous glucose monitor (CGM) shows potential for early hypoglycemia detection in hospitalized patients. Diabetes Technol Ther. In press 2009.
101.
CapesSEHuntDMalmbergKGersteinHC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet.2000;355 (9206): 773–8.
102.
MizockBA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med.1995;98 (1): 75–84.
103.
EspositoKNappoFMarfellaRGiuglianoGGiuglianoFCiotolaMQuagliaroLCerielloAGiuglianoD. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation.2002;106 (16): 2067–72.
104.
YuWKLiWQLiNLiJS. Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. World J Gastroenterol.2003;9 (8): 1824–7.
105.
TurinaMFryDEPolkHCJr.Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med.2005;33 (7): 1624–33.
106.
LukinsMBManninenPH. Hyperglycemia in patients administered dexamethasone for craniotomy. Anesth Analg.2005;100 (4): 1129–33.
107.
FinneySJZekveldCEliaAEvansTW. Glucose control and mortality in critically ill patients. JAMA.2003;290 (15): 2041–7.
FurnaryAPZerrKJGrunkemeierGLStarrA. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg.1999;67 (2): 352–60; discussion 360–2.
110.
GandhiGYNuttallGAAbelMDMullanyCJSchaffHVO'BrienPCJohnsonMGWilliamsARCutshallSMMundyLMRizzaRAMcMahonMM. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med.2007;146 (4): 233–43.
111.
PreiserJC. Restoring normoglycaemia: not so harmless. Crit Care.2008;12 (1): 116.
112.
MeijeringSCorstjensAMTullekenJEMeertensJHZijlstraJGLigtenbergJJ. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit Care.2006;10 (1): R19.
PlankLDHillGL. Energy balance in critical illness. Proc Nutr Soc.2003;62 (2): 545–52.
115.
De BeauxChapmanMFraserRFinnisMDe KeulenaerBLiberalliDSatanekM. Enteral nutrition in the critically ill: a prospective survey in an Australian intensive care unit. Anaesth Intensive Care.2001;29 (6): 619–22.
116.
HeylandDKMacDonaldSKeefeLDroverJW. Total parenteral nutrition in the critically ill patient: a meta-analysis. JAMA.1998;280 (23): 2013–9.
117.
McMahonMMMilesJM. Glycemic control and nutrition in the intensive care unit. Curr Opin Clin Nutr Metab Care.2006;9 (2): 120–3.
118.
HipszerBJosephJKamM. Pharmacokinetics of intravenous insulin delivery in humans with type 1 diabetes. Diabetes Technol Ther.2005;7 (1): 83–93.
119.
WatsonBGElliottMJPayDAWilliamsonM. Diabetes mellitus and open heart surgery. A simple, practical closed-loop insulin infusion system for blood glucose control. Anaesthesia.1986;41 (3): 250–7.
120.
WeinzimerSASteilGMSwanKLDziuraJKurtzNTamborlaneWV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care.2008;31 (5): 934–9.
121.
RenardECostalatGChevassusHBringerJ. Closed loop insulin delivery using implanted insulin pumps and sensors in type 1 diabetic patients. Diabetes Res Clin Pract.200612; 74Suppl 2: S173–7.
